SCHEMBL8166533

SCHEMBL8166533

Cc1ccc(CC=C2SC(=S)NC2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.54
MYC P01106 2/20 0.54
MAX P61244 2/20 0.54
RAB9A P51151 1/20 0.54
CISD1 Q9NZ45 1/20 0.50
NAT1 P18440 3/20 0.49
ADAMTS5 Q9UNA0 1/20 0.47
PIK3CG P48736 2/20 0.47
CA2 P00918 1/20 0.45
EPHX1 P07099 1/20 0.45
PIM1 P11309 1/20 0.44
HPGD P15428 1/20 0.44
PIM2 Q9P1W9 1/20 0.44
CRHBP P24387 2/20 0.44
CRHR2 Q13324 2/20 0.44
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 2/20 0.43
POLB P06746 2/20 0.43
GAA P10253 2/20 0.43
MAPT P10636 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8172015 0.85 MYC (0.61) NPC1MYCMAXRAB9ANAT1
SCHEMBL18102998 0.84 NAT1 (0.59) CISD1NAT1ADAMTS5CA2EPHX1
SCHEMBL8171894 0.84 NAT1 (0.59) CISD1NAT1ADAMTS5CA2EPHX1
SCHEMBL8173323 0.84 CSNK2A2 (0.64) NPC1MYCMAXRAB9ANAT1
SCHEMBL8708384 0.77 PIM1 (0.61) NPC1MYCMAXRAB9ANAT1
SCHEMBL8167436 0.76 PIM1 (0.75) NPC1MYCMAXRAB9ACISD1
SCHEMBL8167434 0.76 PIM1 (0.75) NPC1MYCMAXRAB9ACISD1
SCHEMBL8307763 0.74 NAT1 (0.61) NPC1MYCMAXRAB9ACISD1
SCHEMBL8713697 0.74 NAT1 (0.61) NPC1MYCMAXRAB9ACISD1
SCHEMBL8708264 0.73 PDE4B (0.70) CISD1NAT1ADAMTS5CA2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018748-A1 RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 WO disclosed